The FDA has approved Vascepa (icosapent ethyl) as a secondary therapy to reduce cardiovascular events in adults.
List view / Grid view
Filter the results
Scientists have discovered that liposomes can translocate through the blood brain barrier following stroke and may be able to get drugs to the lesions to stop further damage.
A new observational study has identified no benefit from prescribing statins to healthy pensioners aged over 75 to prevent heart disease...
The results challenged the use of combined oral anticoagulant and antiplatelet therapy in patients with atrial fibrillation, especially those without an indication for antiplatelet therapy.
Scientists in Switzerland have demonstrated that combining a brain-computer interface (BCI) with functional electrical stimulation (FES) can help stroke victims recover greater use of their paralysed limbs – even years after the stroke.
Replacement neurons, blood vessels fill in stroke cavity; gel provides scaffolding...
Machine learning has detected one of the commonest causes of dementia and stroke, in the most widely used form of brain scan (CT), more accurately than current methods.
The mismatch between two MRI methods could signify early stroke status, allowing the use of 'clot-busting' drug...
Patients at risk of heart attacks and strokes may be spotted earlier thanks to a diagnosis tool that uses near-infrared light...
11 May 2017 | By Sarah Wills, Editorial Assistant
An ambitious collaboration between Brainomix, an emerging British business, and Boehringer Ingelheim, one of the world’s largest drug companies, is poised to expedite and improve treatment of stroke, the second biggest killer disease in Europe.
8 February 2017 | By Niamh Marriott, Digital Editor
Keele University stroke specialist Professor Christine Roffe is leading ground breaking clinical trials into a smart chip that could save lives.